Kidney-sparing immunotherapy for lynch syndrome-associated upper tract urothelial carcinoma following colon cancer: a case report. [PDF]
Xie H +8 more
europepmc +1 more source
Pharmacologic Inhibition of PMS2 Induces MMR Deficiency and Response to Immune Checkpoint Blockade. [PDF]
Blagg J +24 more
europepmc +1 more source
Heterogeneity in Clinicopathological and PD-L1 Expression Profiles Across Mismatch Repair Protein Deficiency Patterns in Endometrial Carcinoma. [PDF]
Xiao Y +10 more
europepmc +1 more source
Bayesian Integration of Tumor Mutational Signatures and Somatic Features Refines Pathogenicity Assessment of Germline Mismatch Repair Variants. [PDF]
Amzaleg Y +6 more
europepmc +1 more source
Cancer Risks for PMS2-associated lynch syndrom
Lynch syndrome due to pathogenic variants in the DNA mismatch repair genes MLH1, MSH2, and MSH6 is predominantly associated with colorectal and endometrial cancer, although extracolonic cancers have been described within the Lynch tumor spectrum. However, the age-specific cumulative risk (penetrance) of these cancers is still poorly defined for PMS2 ...
Broeke,Sanne W.Ten +50 more
openaire +1 more source
Reconciling the effects of PMS2 in different repeat expansion disease models supports a common expansion mechanism. [PDF]
Miller CJ +7 more
europepmc +1 more source
Colorectal Carcinoma Metastatic to the Breast Mimicking Inflammatory Breast Cancer With Mismatch Repair Status Discordant From a Prior Endometrial Primary: A Case Report and a Review of the Literature. [PDF]
Walters ML, Figueroa Quast A.
europepmc +1 more source

